Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2012-10-01

Clinical Trial Update: Vaginal Progesterone as a Treatment for Women Active Preterm Labor [NA]

View source ↗

Summary

A clinical trial evaluating vaginal progesterone for women with active preterm labor has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vaginal progesterone (progesterone)

Snippet

Sponsor: University of Rochester | Conditions: Labor, Premature | NA | Status: WITHDRAWN